Point72 Asset Management
WHWK

Point72 Asset Management’s Whitehawk Therapeutics WHWK Stock Holding History

Point72 Asset Management’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$96.7K Buy
+28,026
New +$87.7K ﹤0.01% 3616
2023
Q2 		– Sell
-86
Closed -$623 – 2884
2023
Q1 		$623 Sell
86
-65,980
-100% -$705K ﹤0.01% 2134
2022
Q4 		$848K Sell
66,066
-501,063
-88% -$6.54M ﹤0.01% 1078
2022
Q3 		$8.01M Buy
567,129
+25,085
+5% +$330K 0.03% 575
2022
Q2 		$6.68M Buy
542,044
+330,513
+156% +$4.91M 0.03% 623
2022
Q1 		$3.59M Buy
+211,531
New +$4.05M 0.01% 770
2021
Q1 		– Sell
-16,667
Closed -$245K – 1216
2020
Q4 		$245K Buy
+16,667
New +$356K ﹤0.01% 865

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Point72 Asset Management's WHWK Position: Q1 2026 in Review

Point72 Asset Management opened a new position in Whitehawk Therapeutics (WHWK) in Q1 2026: 28,026 shares worth $96.7K. The stake represents ﹤0.01% of the portfolio and ranks #3616 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in WHWK as recently as Q1 2023.

Point72 Asset Management first reported a position in WHWK in Q4 2020 and has held it in 7 quarters since. The position peaked at $8.01M in Q3 2022. 62 funds tracked by Wall St. Rank hold WHWK as of Q1 2026.

  • Point72 Asset Management held 28,026 shares of Whitehawk Therapeutics worth $96.7K as of Q1 2026.
  • Whitehawk Therapeutics was a new Point72 Asset Management position in Q1 2026.
  • Whitehawk Therapeutics made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #3616 holding.
  • Point72 Asset Management first reported a position in Whitehawk Therapeutics in Q4 2020 and has held it in 7 quarters since.
  • Point72 Asset Management's Whitehawk Therapeutics position peaked at $8.01M in Q3 2022.
  • 62 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.